Jeffrey A. Chodakewitz
Executive Vice President
Management
 Vertex Pharmaceuticals Incorporated
Spain
Biography
Dr. Chodakewitz joined Vertex in January 2014 and is the company’s Executive Vice President, Global Medicines Development and Affairs and Chief Medical Officer. He oversees clinical development, global regulatory affairs, medical affairs, drug safety and other related functions and is responsible for developing, advising and driving execution of Vertex’s clinical development programs. Prior to joining Vertex, Dr. Chodakewitz spent more than 20 years at Merck & Co., Inc., where he held a variety of roles including Vice President of Clinical Research – Infectious Diseases & Vaccines, Vice President of Clinical Pharmacology/Early Stage Development, Senior Vice President of Late Stage Development, and Senior Vice President of Global Scientific Strategy (Infectious Diseases, Respiratory/Immunology). Prior to his tenure at Merck, he served as the Director of the HIV Outpatient Clinic at the Veterans Administration Medical Center in West Haven, Connecticut and held various academic positions at Yale University and New York University Schools of Medicine. Dr. Chodakewitz is a Diplomate of the National Board of Medical Examiners, the American Board of Internal Medicine (both Internal Medicine and Infectious Diseases), and is a member of the Infectious Disease Society of America (IDSA) and the American Society for Clinical Pharmacology & Therapeutics (ASCPT). He received a B.S. in Biochemistry from Yale University, cum laude, and an M.D. from the Yale University School of Medicine.
Research Interest
His area of research interest includes Infectious Disease, Clinical Pharmacology & Therapeutics and Biochemistry
